Ieq Capital »

Entrada Therapeutics shares owned by Ieq Capital

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Ieq Capital from 13F filings

Historical chart of Ieq Capital investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Ieq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Ieq Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $218k 30k 7.36

More positions owned by Ieq Capital

NVIDIA Corporation (NVDA)
Roblox Corp Cl A (RBLX)
Apple (AAPL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Meta Platforms Cl A (META)
Crowdstrike Hldgs Cl A (CRWD)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Series Trust St Str Blo 1 Etf (BIL)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Ieq Capital

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
BlackRock
Merck & Co
Vanguard Capital Management
MPM Oncology Impact Management
TCG Crossover Management
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
AQR Capital Management
State Street Corporation
T. Rowe Price Associates
Jpmorgan Chase & Co

View all funds holding Entrada Therapeutics